Literature DB >> 31116052

Related factors, increased mortality and causes of death in patients with rheumatoid arthritis-associated interstitial lung disease.

Takuya Kakutani1, Atsushi Hashimoto1, Akito Tominaga1, Kako Kodama1, Shinichi Nogi1, Hirotaka Tsuno1, Hideki Ogihara1, Takahiro Nunokawa1, Akiko Komiya2, Hiroshi Furukawa3,4, Shigeto Tohma4,5, Toshihiro Matsui1,4.   

Abstract

Objectives: Interstitial lung disease (ILD) is a life-threatening extra-articular manifestation of rheumatoid arthritis (RA). We aimed to clarify the relationship between chronic ILD with a pattern of usual interstitial pneumonia (UIP) or non-UIP and mortality in RA patients.
Methods: We retrospectively surveyed information of consecutive RA patients who visited our hospital from 2009 to 2014. The relationship between their mortality and chronic ILD (UIP or non-UIP) detected by high-resolution computed tomography was examined.
Results: Of 2702 patients enrolled, 261 (9.7%) had chronic ILD and among these 120 had a UIP pattern. At the onset of RA, the prevalence of chronic ILD was 6%. Patients with chronic ILD had a higher mortality than those without. The most frequent cause of death was pneumonia including acute exacerbation (AE) of chronic ILD. Lung cancer death was frequently identified in deceased patients with chronic ILD with a UIP pattern compared with the other decedents (p=.062). The estimated mortality of lung cancer in patients with chronic ILD with a UIP pattern was five times higher than the general population.
Conclusion: RA patients with ILD with a UIP pattern have a high mortality rate and are prone to die of AE or lung cancer.

Entities:  

Keywords:  Idiopathic pulmonary fibrosis; interstitial lung disease; lung cancer; rheumatoid arthritis; usual interstitial pneumonia

Year:  2019        PMID: 31116052     DOI: 10.1080/14397595.2019.1621462

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

1.  Utility of pulmonary ultrasound to identify interstitial lung disease in patients with rheumatoid arthritis.

Authors:  Natalia Mena-Vázquez; Francisco Gabriel Jimenez-Núñez; Francisco Javier Godoy-Navarrete; Sara Manrique-Arija; María Carmen Aguilar-Hurtado; Carmen María Romero-Barco; Inmaculada Ureña-Garnica; F Espildora; María Isabel Padin-Martín; Antonio Fernández-Nebro
Journal:  Clin Rheumatol       Date:  2021-02-21       Impact factor: 2.980

2.  Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMJ Open       Date:  2021-03-31       Impact factor: 2.692

3.  Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.

Authors:  Shomi Oka; Takashi Higuchi; Hiroshi Furukawa; Kota Shimada; Akira Okamoto; Atsushi Hashimoto; Akiko Komiya; Koichiro Saisho; Norie Yoshikawa; Masao Katayama; Toshihiro Matsui; Naoshi Fukui; Kiyoshi Migita; Shigeto Tohma
Journal:  BMC Musculoskelet Disord       Date:  2022-01-13       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.